Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria.
Forcadela M, Rocchi C, San Martin D, Gibbons EL, Wells D, Woodhall MR, Waters PJ, Huda S, Hamid S. Forcadela M, et al. Among authors: woodhall mr. Neurol Neuroimmunol Neuroinflamm. 2023 Nov 17;11(1):e200183. doi: 10.1212/NXI.0000000000200183. Print 2024 Jan. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37977848 Free PMC article.
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.
Kim SM, Woodhall MR, Kim JS, Kim SJ, Park KS, Vincent A, Lee KW, Waters P. Kim SM, et al. Among authors: woodhall mr. Neurol Neuroimmunol Neuroinflamm. 2015 Oct 15;2(6):e163. doi: 10.1212/NXI.0000000000000163. eCollection 2015 Dec. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 26516628 Free PMC article.
IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG.
Huda S, Waters P, Woodhall M, Leite MI, Jacobson L, De Rosa A, Maestri M, Ricciardi R, Heckmann JM, Maniaol A, Evoli A, Cossins J, Hilton-Jones D, Vincent A. Huda S, et al. Neurol Neuroimmunol Neuroinflamm. 2017 Jun 5;4(4):e357. doi: 10.1212/NXI.0000000000000357. eCollection 2017 Jul. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28626780 Free PMC article.
Clinical presentation and prognosis in MOG-antibody disease: a UK study.
Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, Tackley G, Hamid S, Sheard A, Reynolds G, Chandratre S, Hemingway C, Jacob A, Vincent A, Leite MI, Waters P, Palace J. Jurynczyk M, et al. Among authors: woodhall mr. Brain. 2017 Dec 1;140(12):3128-3138. doi: 10.1093/brain/awx276. Brain. 2017. PMID: 29136091
International multicenter examination of MOG antibody assays.
Reindl M, Schanda K, Woodhall M, Tea F, Ramanathan S, Sagen J, Fryer JP, Mills J, Teegen B, Mindorf S, Ritter N, Krummrei U, Stöcker W, Eggert J, Flanagan EP, Ramberger M, Hegen H, Rostasy K, Berger T, Leite MI, Palace J, Irani SR, Dale RC, Probst C, Probst M, Brilot F, Pittock SJ, Waters P. Reindl M, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Feb 5;7(2):e674. doi: 10.1212/NXI.0000000000000674. Print 2020 Mar 5. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32024795 Free PMC article.
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?
Chen B, Gomez-Figueroa E, Redenbaugh V, Francis A, Satukijchai C, Wu Y, Messina S, Sa M, Woodhall M, Paul F, Robertson NP, Lim M, Wassmer E, Kneen R, Huda S, Blain C, Halfpenny C, Hemingway C, O'Sullivan E, Hobart J, Fisniku LK, Martin RJ, Dobson R, Cooper SA, Williams V, Waters P, Chen JJ, Pittock SJ, Ramdas S, Leite MI, Flanagan EP, Geraldes R, Palace J. Chen B, et al. Ann Neurol. 2023 Sep;94(3):508-517. doi: 10.1002/ana.26731. Epub 2023 Jul 12. Ann Neurol. 2023. PMID: 37394961
Predictors of relapse in MOG antibody associated disease: a cohort study.
Huda S, Whittam D, Jackson R, Karthikeayan V, Kelly P, Linaker S, Mutch K, Kneen R, Woodhall M, Murray K, Hunt D, Waters P, Jacob A. Huda S, et al. BMJ Open. 2021 Nov 30;11(11):e055392. doi: 10.1136/bmjopen-2021-055392. BMJ Open. 2021. PMID: 34848526 Free PMC article.
90 results